Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Protalix BioTherapeutics, Inc. (DE) Common Stock (NY:PLX)

2.005 +0.225 (+12.64%)
Streaming Delayed Price Updated: 12:44 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Protalix BioTherapeutics, Inc. (DE) Common Stock

< Previous 1 2 3 4 Next >
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
On Friday morning, 7 companies hit new 52-week lows. Key Facts: The largest company by market cap to set a new 52-week low was TAL Education (NYSE:TAL). The company... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday morning, 11 companies achieved new lows for the year. Intriguing Points: TAL Education (NYSE:TAL) was the biggest company on a market cap basis to set a new 52... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Constellation Pharmaceuticals Surges Following Acquisition News; Protalix BioTherapeutics Shares Slide ↗
Toward the end of trading Wednesday, the Dow traded up 0.05% to 34,594.18 while the NASDAQ fell 0.16% to 13,715.08. The S&P also rose, gaining 0.02% to 4,202.76. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Mid-Day Market Update: Crude Oil Rises 1%; iRhythm Technologies Shares Plunge ↗
`Midway through trading Wednesday, the Dow traded up 0.33% to 34,689.77 while the NASDAQ rose 0.16% to 13,758.43. The S&P also rose, gaining 0.30% to 4,214.55. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
66 Biggest Movers From Yesterday ↗
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped... 
Via Benzinga
News headline image
Protalix Shares Hits 52-Week Low After Adverse Event Reported In Fabry Disease Trial With PRX-102 ↗
Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Farmaceutici S.p.A. have provided an update on the clinical development of pegunigalsidase alfa (PRX... 
Via Benzinga
News headline image
40 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
Before 10 a.m. ET on Wednesday, 8 companies hit new 52-week lows. Highlights: Dun & Bradstreet Hldgs (NYSE:DNB) was the biggest company by market cap to set a new 52-... 
Via Benzinga
News headline image
Looking Into Protalix BioTherapeutics's Return On Capital Employed ↗
Protalix BioTherapeutics (AMEX:PLX) reported Q1 sales of $11.32 million. Earnings fell to a loss of $3.71 million, resulting in a 230.5% decrease from last quarter. In Q4,... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
Before 10 a.m. ET on Friday, 24 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was Canadian... 
Via Benzinga
News headline image
Earnings Scheduled For May 14, 2021 ↗
Companies Reporting Before The Bell • Sogou (NYSE:SOGO) is projected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is estimated to report... 
Via Benzinga
News headline image
Earnings Preview for Protalix BioTherapeutics ↗
On Friday, May 14, Protalix BioTherapeutics (AMEX:PLX) will release its latest earnings report. Here is Benzinga's outlook for the company. Net Income, Earnings, And Earnings Per... 
Via Benzinga
News headline image
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
News headline image
22 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn... 
Via Benzinga
News headline image
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Drops 90 Points; Fed Leaves Rates Unchanged ↗
Toward the end of trading Wednesday, the Dow traded down 0.26% to 33,894.93 while the NASDAQ fell 0.01% to 14,090.09. However, the S&P gained 0.13% to 4,192.05. The U.S. has... 
Via Benzinga
Topics Economy Stocks
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of... 
Via Benzinga
News headline image
Why Protalix BioTherapeutics Stock Is Plunging Today ↗
Investors did not like the company's latest regulatory update. 
Via The Motley Fool
News headline image
Mid-Day Market Update: Crude Oil Rises 2%; Protalix BioTherapeutics Shares Plunge ↗
Midway through trading Wednesday, the Dow traded down 0.33% to 33,874.02 while the NASDAQ fell 0.07% to 14,079.66. The S&P also rose, gaining 0.15% to 4,193.17. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
41 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Mixed; Alphabet Tops Q1 Expectations ↗
Following the market opening Wednesday, the Dow traded down 0.43% to 33,839.68 while the NASDAQ rose 0.10% to 14,104.41. The S&P also rose, gaining 0.19% to 4,194.68. The U.S... 
Via Benzinga
Topics Stocks
News headline image
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
News headline image
25 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today.... 
Via Benzinga
News headline image
Protalix Stock Falls After FDA Slaps CRL For PRX-102 Application In Fabry Disease ↗
Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici, have received a Complete Response... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
News headline image
Understanding Protalix BioTherapeutics's Unusual Options Activity ↗
Protalix BioTherapeutics (AMEX:PLX) shares experienced unusual options activity on Monday. The stock price moved up to $6.25 following the option alert. Sentiment: BEARISH Option... 
Via Benzinga
News headline image
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.